<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0019343" disease_type="Disease or Syndrome" abbrv="">Herpes gestationis</z:e> shares many features with other bullous diseases, especially <z:e sem="disease" ids="C0030805" disease_type="Disease or Syndrome" abbrv="">bullous pemphigoid</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Treatments of benefit in <z:e sem="disease" ids="C0030805" disease_type="Disease or Syndrome" abbrv="">bullous pemphigoid</z:e> may also be effective for <z:e sem="disease" ids="C0019343" disease_type="Disease or Syndrome" abbrv="">herpes gestationis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi>, <z:chebi fb="2" ids="2948">azathioprine</z:chebi>, and other <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> have been used successfully in refractory cases of <z:e sem="disease" ids="C0030805" disease_type="Disease or Syndrome" abbrv="">bullous pemphigoid</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We describe a patient with severe and persistent <z:e sem="disease" ids="C0019343" disease_type="Disease or Syndrome" abbrv="">herpes gestationis</z:e> in the postpartum period and the <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome, both of which were refractory to high-dose <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Treatment with pulsed-dose intravenous <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> produced an excellent clinical response </plain></SENT>
</text></document>